Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study
Authors
Keywords
-
Journal
EYE
Volume 30, Issue 8, Pages 1063-1071
Publisher
Springer Nature
Online
2016-05-21
DOI
10.1038/eye.2016.90
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration According to LUCAS Treat-and-Extend Protocol
- (2015) Karina Berg et al. OPHTHALMOLOGY
- Patients with Knee Osteoarthritis Undergoing Total Knee Arthroplasty Have a Lower Risk of Subsequent Severe Cardiovascular Events: Propensity Score and Instrumental Variable Analysis
- (2015) Wen-Yan Lin et al. PLoS One
- Association between the unemployment rate and inpatient cost per discharge by payer in the United States, 2005–2010
- (2014) Jared Lane K Maeda et al. BMC HEALTH SERVICES RESEARCH
- Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)
- (2014) Ursula Schmidt-Erfurth et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration
- (2014) Frank G Holz et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Progressive dysfunction of the retinal pigment epithelium and retina due to increased VEGF-A levels
- (2014) Zsolt Ablonczy et al. FASEB JOURNAL
- Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration
- (2013) Brandon G. Busbee et al. OPHTHALMOLOGY
- Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
- (2012) Daniel F. Martin et al. OPHTHALMOLOGY
- Improving bias and coverage in instrumental variable analysis with weak instruments for continuous and binary outcomes
- (2012) Stephen Burgess et al. STATISTICS IN MEDICINE
- Fixed Monthly versus Less Frequent Ranibizumab Dosing and Predictors of Visual Response in Exudative Age-Related Macular Degeneration
- (2012) Seenu M. Hariprasad et al. Journal of Ophthalmology
- Safety and Efficacy of a Flexible Dosing Regimen of Ranibizumab in Neovascular Age-Related Macular Degeneration: The SUSTAIN Study
- (2011) Frank G. Holz et al. OPHTHALMOLOGY
- Efficacy and Safety of Monthly versus Quarterly Ranibizumab Treatment in Neovascular Age-related Macular Degeneration: The EXCITE Study
- (2010) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGY
- Instrumental variable methods in comparative safety and effectiveness research
- (2010) M. Alan Brookhart et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Optische Kohärenztomographie in der Makuladiagnostik
- (2009) A. Hassenstein et al. OPHTHALMOLOGE
- Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1
- (2008) Carl D. Regillo et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More